PUBLISHER: The Business Research Company | PRODUCT CODE: 1816525
PUBLISHER: The Business Research Company | PRODUCT CODE: 1816525
Nucleic acid isolation and purification involve the separation of DNA and/or RNA from cellular components like proteins and membranes. The primary aim is to break down the cell structure and eliminate lipids and proteins, achieving pure DNA and/or RNA.
Diverse types of nucleic acid isolation and purification methods include plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, micro-RNA isolation and purification, PCR cleanup, and other techniques. Plasmid DNA isolation and purification focus on isolating plasmid DNA from genomic DNA, proteins, ribosomes, and bacterial cell walls. Plasmids, circular double-stranded DNA structures, carry specific DNA molecules. These methods encompass column-based, magnetic bead-based, reagent-based, and various other methods applied in diagnostics, drug discovery, personalized medicine, agriculture, animal research, and diverse applications. End-users of these processes include academic and research institutions, biopharmaceutical and biotechnological companies, contract research organizations, applied testing facilities, clinical diagnostic centers, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a notable impact on the services sector, particularly in business services, IT, and professional consulting. The increased costs of imported technology, office equipment, and critical digital infrastructure are driving up operating expenses for service providers, compelling them to either pass these costs on to clients or absorb the financial strain themselves. Outsourcing firms and IT service providers are grappling with higher hardware costs and supply chain delays, which are disrupting project timelines and squeezing profitability. Furthermore, retaliatory tariffs have weakened demand for U.S.-based professional services in key global markets, slowing export-driven revenues. To navigate these challenges, the sector must focus on accelerating digital transformation, optimizing costs, and strengthening domestic client relationships to sustain growth and remain competitive in an increasingly uncertain trade environment.
The nucleic acid isolation and purification market research report is one of a series of new reports from The Business Research Company that provides nucleic acid isolation and purification market statistics, including nucleic acid isolation and purification industry global market size, regional shares, competitors with a nucleic acid isolation and purification market share, detailed nucleic acid isolation and purification market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid isolation and purification industry. This nucleic acid isolation and purification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nucleic acid isolation & purification market size has grown strongly in recent years. It will grow from $6.03 billion in 2024 to $6.6 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to genomic research advancements, emergence of molecular diagnostics, biotechnology industry growth, focus on infectious disease research, forensic applications.
The nucleic acid isolation & purification market size is expected to see rapid growth in the next few years. It will grow to $10.37 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to research collaborations and funding, automation and high-throughput solutions, point-of-care testing demand, agricultural and food science applications, pharmaceutical drug development. Major trends in the forecast period include sustainability in bioprocessing, focusing on automation, adoption of next-generation sequencing, advancements in genomic research, and emergence of personalized medicine.
The forecast of 11.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The U.S. could face higher lab testing costs as spin columns, magnetic bead kits, and lysis buffers sourced from the UK and Germany become more expensive to use in genomic and clinical workflows. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The advancement of personalized medicine is anticipated to drive growth in the nucleic acid isolation and purification market. Personalized medicine enables healthcare providers to create tailored treatment plans and make informed treatment decisions based on a genetic understanding of each patient's condition. Nucleic acid isolation and purification techniques are essential for processes like sequencing, cloning, and polymerase chain reaction (PCR), which help identify the underlying causes of diseases and facilitate the prescription of targeted precision medicines. For example, in February 2024, data from the Personalized Medicine Coalition (PMC), a U.S.-based nonprofit umbrella organization, revealed that the FDA approved 16 new personalized treatments for rare diseases in 2023, a notable increase from just six approvals in 2022. Consequently, the growth of personalized medicine is set to propel the nucleic acid isolation and purification market in the future.
The rising incorporation of automation in production processes is poised to propel the nucleic acid isolation and purification market. Automation, utilizing technology like robotics, streamlines tasks that traditionally demanded manual intervention. In March 2022, reports indicated a substantial uptake of automation in Indian manufacturing industries, predicting that by 2050, approximately 85-90% of these firms would adopt automated operations. This trend toward automation is forecasted to be a driving force in advancing nucleic acid isolation and purification methodologies.
Technological advancements emerge as a prominent trend fueling the nucleic acid isolation and purification market. Key industry players are diligently focusing on innovating technologies to maintain their market stance. Notably, Sansure Biotech's introduction of the Natch 16S system in July 2023, equipped with magnetic bead technology, UV lamp, and air filtration solutions, stands as a testament to this pursuit of sophisticated solutions leveraging complex technologies. This drive for innovation is reshaping methodologies within the market.
Major companies within the nucleic acid isolation and purification sector are actively developing innovative products, notably nucleic acid extraction kits. These kits, designed to isolate DNA and RNA from diverse sources, are pivotal in diagnostics and research. For instance, Jiangsu Bioperfectus Technologies Co., Ltd's launch of the Automated Nucleic Acid Extraction Workstation SAW-48 and Cell Nucleic Acid Extraction Kit in April 2023 showcases the evolution in diagnostic medical equipment. The integration of SAW-48 with the Cell Nucleic Acid Extraction Kit enhances efficiency, reduces turnaround time, and heightens accuracy while minimizing exposure risks for laboratory personnel.
In January 2023, ALS Limited, an Australia-based company specializing in testing laboratories, successfully acquired Invitek Molecular for an undisclosed sum. This strategic acquisition showcases ALS' dedication to broadening their expertise in testing and bolstering their service offerings, aimed at delivering comprehensive solutions to their clientele. Invitek Molecular, a Germany-based company, specializes in offering customized nucleic acid purification solutions.
Major companies operating in the nucleic acid isolation & purification market are Thermo Fisher Scientific Inc., Illumina Inc., F. Hoffmann-La Roche AG, Merck KGaA, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Takara Bio Inc., Promega Corporation, New England Biolabs, Norgen Biotek Corporation, AutoGen Inc., MagGenome, Zymo Research, LGC Limited, Biogenuix, PCR Biosystems Inc., Abcam plc., PerkinElmer Inc., GE Healthcare, QIAGEN, Danaher Corporation, Bioline, Biotechrabbit, BioWORLD, Epicentre, Hamilton, Omega Bio-tek, Sigma-Aldrich, FavorGen Biotech Corp, TIANGEN Biotech Co Ltd.
North America was the largest region in the nucleic acid isolation & purification market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid isolation & purification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the nucleic acid isolation & purification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The nucleic acid isolation and purification market includes revenues earned by entities from the extraction of DNA from animal and plant tissues, cultured mammalian cells, bacteria, and yeast cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Nucleic Acid Isolation & Purification Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on nucleic acid isolation & purification market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for nucleic acid isolation & purification ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nucleic acid isolation & purification market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.